Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation
- PMID: 8532022
- DOI: 10.1056/NEJM199602013340501
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation
Abstract
Background: Graft-versus-host disease (GVHD) can be a major complication of allogeneic bone marrow transplantation even when the donor and recipient are siblings and share identical major histocompatibility antigens. The explanation may be a mismatch of minor histocompatibility antigens. We previously characterized five minor histocompatibility antigens, HA-1, 2, 3, 4, and 5, that are recognized by T cells in association with the major histocompatibility antigens HLA-A1 an A2.
Methods: We collected peripheral-blood leukocytes from 148 bone marrow recipients and their sibling donors, who were genotypically HLA identical. Fifty pairs were positive for HLA-A1, 117 were positive for HLA-A2, and 19 were positive for both. The pairs were typed with cytotoxic-T-cell clones specific for minor histocompatibility antigens HA-1, 2, 3, 4, and 5.
Results: Mismatches of HA-3 were equally distributed among recipients in whom GVHD developed and those in whom it did not. By contrast, a mismatch of only HA-1 was significantly correlated with GVHD of grade II or higher (odds ratio, infinity; P = 0.02) in adults. One or more mismatches of HA-1, 2, 4, and 5 were also significantly associated with GVHD (odds ratio, infinity; P = 0.006) in adults. These associations were not observed in children.
Conclusions: A mismatch of minor histocompatibility antigen HA-1 can cause GVHD in adult recipients of allogeneic bone marrow from HLA-identical donors. Prospective HA-1 typing may improve donor selection and identify recipients who are at high risk for GVHD.
Comment in
-
Minor histocompatibility antigens and marrow transplantation.N Engl J Med. 1996 Feb 1;334(5):323-4. doi: 10.1056/NEJM199602013340510. N Engl J Med. 1996. PMID: 8532031 No abstract available.
Similar articles
-
Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.Nat Med. 1999 Jul;5(7):839-42. doi: 10.1038/10563. Nat Med. 1999. PMID: 10395333
-
No significant association between HA-1 incompatibility and incidence of acute graft-versus-host disease after HLA-identical sibling bone marrow transplantation in Japanese patients.Int J Hematol. 2000 Oct;72(3):371-5. Int J Hematol. 2000. PMID: 11185997
-
Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.Dan Med Bull. 2002 May;49(2):89-108. Dan Med Bull. 2002. PMID: 12064093 Review.
-
Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.Bone Marrow Transplant. 1997 May;19(10):1001-9. doi: 10.1038/sj.bmt.1700779. Bone Marrow Transplant. 1997. PMID: 9169644
-
Increased disparity for minor histocompatibility antigens as a potential cause of increased GVHD risk in marrow transplantation from unrelated donors compared with related donors.Bone Marrow Transplant. 1991 Sep;8(3):217-23. Bone Marrow Transplant. 1991. PMID: 1958902 Review.
Cited by
-
Trophoblast expression of the minor histocompatibility antigen HA-1 is regulated by oxygen and is increased in placentas from preeclamptic women.Placenta. 2015 Aug;36(8):832-8. doi: 10.1016/j.placenta.2015.05.018. Epub 2015 Jun 6. Placenta. 2015. PMID: 26095815 Free PMC article.
-
Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model.Blood. 2006 Mar 1;107(5):2045-51. doi: 10.1182/blood-2005-07-2828. Epub 2005 Nov 3. Blood. 2006. PMID: 16269613 Free PMC article.
-
Milestones in acute GVHD pathophysiology.Front Immunol. 2022 Dec 5;13:1079708. doi: 10.3389/fimmu.2022.1079708. eCollection 2022. Front Immunol. 2022. PMID: 36544776 Free PMC article. Review.
-
New perspectives on the biology of acute GVHD.Bone Marrow Transplant. 2010 Jan;45(1):1-11. doi: 10.1038/bmt.2009.328. Epub 2009 Nov 30. Bone Marrow Transplant. 2010. PMID: 19946340 Free PMC article. Review.
-
Graft-Versus-Solid-Tumor Effect: From Hematopoietic Stem Cell Transplantation to Adoptive Cell Therapies.Stem Cells. 2022 Jun 22;40(6):556-563. doi: 10.1093/stmcls/sxac021. Stem Cells. 2022. PMID: 35325242 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials